Previous 10 | Next 10 |
NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the Company is set to join the small-cap Russell 2000 ® Index and the ...
NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that medical diagnostics pioneer Stanley Lapidus, founder and former Chairma...
YONKERS, N.Y., June 15, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of ...
The U.S. Centers for Medicare and Medicaid Services (CMS) has established preliminary reimbursement recommendations for PAVmed ( PAVM -0.2% ) subsidiary Lucid Diagnostics' EsoGuard Esophageal DNA test, a screening test for precursors to esophageal adenocarcinoma in patients with chronic ...
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its majority owned subsidiary, Lucid Diagnostics Inc. (“Lucid...
Executed LOI with Canon Virginia, Inc. to develop and implement commercial grade processes to manufacture molded resorbable pediatric ear tubes from aqueous silk fibroin NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or ...
Westwater Resources (NASDAQ: WWR ) +144% on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
PAVmed ( PAVM ) has a collection of products that are in various states of regulatory clearance, but taken together these have a market opportunity in the billions of dollars. While good progress has been made, the company's immediate commercialization efforts for three of its products (EsoG...
Recon Technology (NASDAQ: RCON ) -38% on ~$2.1M registered direct offering . More news on: Recon Technology, Ltd., Geron Corporation, Syndax Pharmaceuticals, Inc., Stocks on the move, , Read more ...
PAVmed Inc. (PAVM) Q1 2020 Results Earnings Conference Call May 21, 2020, 04:30 PM ET Company Participants Mike Havrilla - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - President & Chief Financial Officer Conference Call Participants Anthony Vendetti -...
News, Short Squeeze, Breakout and More Instantly...
PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024 PR Newswire Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , July 30, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) ("PAVmed" or the "C...
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , July 29, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Luc...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...